Общество с ограниченной ответственностью "Парафарм" (RU)
发明人:
Струков Виллорий Иванович (RU),Ковалев Анатолий Александрович (RU),Животощук Вадим Сергеевич (RU)
申请号：
RU2014134401
公开号：
RU2014134401A
申请日:
2014.08.22
申请国别(地区):
RU
年份:
2016
代理人:
摘要：
1. A method for treating joint diseases, osteoporosis prone comprising conducting pharmacological treatment, consisting in reception androgenogeneza stimulator in an amount of 20-1000 mg in combination with vitamin D3 in an amount of 100-50000 ME and at least one calcium compound in an amount of 40-1000 mg at least once a day for at least one month, after which combine a pharmacological treatment with short-wave therapy, in which the plurality of different frequency coherent EHF radiation is combined into a single aggregate l uch that is fed consecutively on the skin sites located in projections painful periarticular tissues, and is carried by at least one course of therapy EHF consisting of at least one session, whose duration is at least 5 min.2. The method of claim. 1, characterized in that it is intended for the treatment of small sustavov.3. A method according to claim. 2, characterized in that it is intended for the treatment of joints of the hands and stop.4. The method of claim. 1, characterized in that the stimulator used androgenogeneza rasplod.5 drone. The method of claim. 1, characterized in that the calcium compounds are used as a calcium citrate and / or carbonate kaltsiya.6. The method of claim. 1, characterized in that the pharmacologic treatment before carrying out short-wave therapy is performed up to 10 months vklyuchitelno.7. The method of claim. 1, characterized in that the EHF-therapy course consists of at least two sessions.1. Способ лечения заболеваний суставов, подверженных остеопорозу, включающий проведение фармакологического лечения, заключающегося в приеме стимулятора андрогеногенеза в количестве 20-1000 мг в сочетании с витамином D3 в количестве 100-50000 ME и по меньшей мере одним соединением кальция в количестве 40-1000 мг по меньшей мере один раз в день на протяжении по меньшей мере одного месяца, после чего сочетают такое фармакологическое лечение с КВЧ-терапией, при которой совокупность разночастотных когерентных КВЧ-излучений совме
